Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s ...

NImmune Biopharma ("NImmune"), a private late-stage precision inflammation and immunology ("I&I") biopharmaceutical company, today announced that Executive Chairman, President and CEO Dr. Josep ...

Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn’s disease; Phase 2 ulcerative ...

A new study suggests that combining routine stool tests and tracking habitual dietary patterns could help to predict IBD ...

Sanofi and Teva had already shown in late 2024 that the anti-TL1A antibody, called duvakitug, improved outcomes in ulcerative ...

Ulcerative colitis, a form of IBD, can change how your stool looks, smells, and feels. Learn what UC poop looks like during a ...

The Department of Defense is tapping a research team led by Mount Sinai to study a novel treatment for ulcerative colitis, an enemy within that disproportionately impacts individuals in the military.

While some studies suggest CBD oil may help reduce inflammation and provide symptomatic relief for ulcerative colitis, more research is needed to confirm its effectiveness. The FDA has not approved ...

'Imagine having a wound that never heals. Only it’s on the inside and every time you eat or drink, it’s like rubbing salt into that wound.' When asked to explain the sensation of ulcerative colitis, ...

Mesalamine is a medicine for ulcerative colitis (UC) and other types of inflammatory bowel disease (IBD). It belongs to a group of anti-inflammatory medicines called aminosalicylates or ...

Being diagnosed with ulcerative colitis (UC) can be stressful and a bit scary. A type of autoimmune condition, UC is an inflammatory bowel disease that affects between 600,000 and 900,000 Americans, ...

News and commentary from the world of gastroenterology and hepatology ...